Erly Pen Injection

Erly Pen Injection contains Liraglutide, a GLP-1 receptor agonist used for managing type 2 diabetes and aiding weight loss.

Uses:
✔ Type 2 Diabetes Mellitus – Helps lower blood sugar levels effectively.
✔ Weight Management – Approved for weight loss in obese and overweight individuals.
✔ Cardiovascular Risk Reduction – Reduces the risk of heart attack and stroke in diabetic patients.

How Erly Pen Works:
Liraglutide mimics the GLP-1 hormone, which regulates blood sugar and appetite. It slows digestion, increases insulin secretion, and reduces hunger, aiding both diabetes control and weight loss.

Common Side Effects:
🔹 Nausea
🔹 Vomiting
🔹 Diarrhea
🔹 Decreased appetite
🔹 Injection site reactions

Serious Side Effects (Seek Medical Help):
⚠️ Pancreatitis (severe abdominal pain)
⚠️ Thyroid tumors (rare but serious)
⚠️ Kidney issues (dehydration, low urine output)
⚠️ Gallbladder problems (severe stomach pain, yellowing of skin)

Precautions:
⚡ Pregnancy & Breastfeeding: Not recommended.
⚡ Thyroid Disease: Avoid if you have a history of thyroid tumors.
⚡ Kidney & Liver Conditions: Use with caution.
⚡ Avoid Alcohol: Can increase the risk of low blood sugar.

FAQs:

1. How is Erly Pen Injection administered?
   It is injected subcutaneously (under the skin) once daily, as prescribed.

2. Can Erly Pen help with weight loss?
   Yes, it is approved for weight management in obese individuals.

3. How soon does Erly Pen start working?
   Blood sugar control effects are seen within a few weeks, while weight loss takes longer.

4. Can I use Erly Pen if I am not diabetic?
   Yes, it is prescribed for weight loss even in non-diabetic patients.

5. Where can I buy Erly Pen Injection online?
   Order from Milan Medicals for authentic products and worldwide shipping.

References:
🔗 https://www.mayoclinic.org/drugs-supplements/liraglutide-subcutaneous-route/description/drg-20073828
🔗 https://reference.medscape.com/drug/victoza-saxenda-liraglutide-999449